Gwan Yip
About Gwan Yip
Gwan Yip is Chief Product Officer (CPO) of Amaze Holdings, Inc., appointed effective June 13, 2025, overseeing both Product and Engineering to drive creator‑commerce product strategy and execution . Prior to Amaze, he was CEO and Co‑Founder of Core3D, a web‑based 3D design platform that partnered with brands like Theory and Brooks Brothers; he also founded a product‑focused development agency and earlier built eCommerce divisions for fashion retailers in the early 2000s . Company filings and press releases to date do not disclose TSR, revenue growth, or EBITDA growth metrics tied to his tenure .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Amaze Holdings, Inc. | Chief Product Officer | 2025–present | Leads Product and Engineering to scale a creator‑commerce platform and align product roadmap with growth initiatives . |
| Core3D | CEO & Co‑Founder | Pre‑2025 | Built a web‑based 3D design platform; partnered with brands such as Theory and Brooks Brothers . |
| Product‑focused development agency | Founder | Pre‑Core3D | Led product development services enabling rapid product innovation for clients . |
| Multiple fashion retailers | eCommerce leader | Early 2000s | Established and grew eCommerce divisions for fashion/retail, building product‑centric businesses . |
External Roles
- None disclosed in company filings or IR materials reviewed .
Fixed Compensation
- Not disclosed. The 2025 proxy covers FY2024 and lists named executive officers that do not include Yip; no base salary, target bonus, or cash pay details for Yip appear in filings to date. The June 18, 2025 8‑K and accompanying press release announce his appointment but do not describe compensatory arrangements .
Performance Compensation
- No Yip‑specific incentive plan metrics, weighting, targets, or payouts are disclosed in current filings .
- Plan context: Amaze’s Amended and Restated 2021 Equity Incentive Plan authorizes equity awards (options, RSUs, performance awards) up to 20,800,000 shares pre‑reverse‑split basis, with performance awards permitted at the committee’s discretion; however, no award grants or vesting schedules specific to Yip are reported yet .
Equity Ownership & Alignment
- Beneficial ownership: Yip does not appear in the FY2024 named executive officer ownership tables; no Form 5/beneficial owner table entry for Yip is disclosed in the May 7, 2025 proxy; the June 2025 8‑K/press releases likewise do not quantify his holdings .
- Shares outstanding context: 5,277,810 common shares were outstanding as of June 16, 2025 after the 1‑for‑23 reverse stock split and Series D conversion—useful baseline for assessing any future reported ownership percentages .
- Hedging/pledging policy: Insider trading policy prohibits short sales and hedging; pledging or margin accounts require advance consent from the compliance officer—mitigating misalignment risk signals (hedging/pledging) .
- Stock ownership guidelines: Not disclosed in the proxy reviewed .
Employment Terms
- Start date/role: Appointed Chief Product Officer effective June 13, 2025 .
- Employment agreement, severance, change‑of‑control, vesting acceleration, non‑compete, and clawback terms: Not disclosed for Yip in the June 18, 2025 8‑K or the May 7, 2025 proxy. The proxy notes the company did not have employment agreements with its FY2024 named executive officers, but Yip was not among those NEOs; no separate 8‑K Item 5.02 detailing a Yip employment agreement was found in the filings consulted .
Governance and Compensation Committee Context
- Compensation Committee: One independent director (Eric Doan) serves as the compensation committee and administers the equity plan and officer pay, indicating centralized oversight of incentives .
- Broader equity authorization: Board sought and disclosed a substantial equity plan share reserve to support retention and incentives, subject to reverse split adjustments, signaling potential for meaningful equity‑based compensation across executives going forward .
Risk Indicators & Red Flags (monitoring list)
- Dilution mechanics: Recent share count reset (Series D conversion plus 1‑for‑23 reverse split) and expanded equity plan capacity increase future dilution sensitivity as equity awards are granted .
- Hedging/pledging: Policy restricts hedging and requires consent for pledging—positive alignment signal if enforced; monitor for any exceptions filed .
- Disclosure gaps: Lack of disclosed CPO‑specific pay metrics, vesting schedules, or employment protections—watch the next proxy and any Item 5.02 8‑Ks for material compensatory arrangements .
Investment Implications
- Execution upside: Yip’s deep product/eCommerce background (Core3D, agency leadership, early retail eCommerce buildouts) aligns with Amaze’s need to scale a differentiated product and integrated engineering roadmap in creator commerce—supportive for product velocity and platform fit if resourced adequately .
- Incentive transparency: With no Yip‑specific compensation metrics or equity grants disclosed, alignment and retention levers are not yet visible; the enlarged equity plan suggests future equity‑based incentives are likely—monitor the next proxy and Form 4s for grant sizing, vesting cadence, and performance linkages .
- Capital structure sensitivity: Post‑split share base of 5.28M and prior preferred conversions heighten dilution and overhang considerations; product milestones under Yip that translate to monetization and creator growth will be critical to offset potential dilution from future equity issuance .
References:
- Appointment and role details (8‑K press release exhibit): “Amaze Announces New Officer Appointments” (effective June 13, 2025) .
- Executive background and role scope: Amaze IR press release (Mar 26, 2025) and IR Executive Team page .
- Shares outstanding and reverse split disclosure: 8‑K (June 18, 2025) .
- Equity plan and compensation committee governance: DEF 14A (May 7, 2025) .
- Insider trading, hedging, and pledging restrictions: DEF 14A (May 7, 2025) .
- NEO list for FY2024 (Yip not included) and absence of CPO compensation terms in filings reviewed: DEF 14A (May 7, 2025) and 8‑K (June 18, 2025) .